Mount Sinai Reveals Psychedelic Drugs' Therapeutic Potential

The New England Journal of Medicine Shines Spotlight on Forensic Pathology

Gut Microbiome Composition and Food Insecurity Linked to Risk of Cognitive Impairment in Adults

Mount Sinai Health System Brings Bold Ideas in AI and Healthspan Science to Aspen 2025

Mount Sinai Receives $3.8 Million Grant to Study New Synthetic Drugs and Opioid Overdoses in Emergency Departments to Prevent Deaths

New Framework for Characterizing Traumatic Brain Injury To Reveal More Detail About Patient’s Condition and Potential for Recovery

Mount Sinai Researchers Uncover a Promising New Way to Modulate Brain Cell Activity to Potentially Treat Major Depressive Disorder in Adults

Women Whose Sister Experienced Postpartum Psychosis Are More Than 10 Times as Likely to Experience It Themselves, According to New Research

Academy Award-Nominated Movie Helps Researchers Identify Brain Region Biased Towards Drug Cues and Treatment Effects in Individuals With Heroin Use Disorder

Mount Sinai Health System to Honor Dennis S. Charney, MD, Dean of the Icahn School of Medicine at Mount Sinai, for 18 Years of Leadership and Service at Annual Crystal Party

Mount Sinai Researchers in Semifinals of $101 Million XPRIZE Healthspan, a Competition Seeking Innovative Approaches to Aging Well

Discovery of Dopamine Receptors in a Previously Overlooked Part of the Brain Sheds Light on the Complex Circuitry for Anxiety and Depression